IUGR
Intrauterine growth restriction is said to be present in those babies whose birth weight is below the tength percentile of the average for gestational age.
INCIDENCE
Dysmaturity comprised about one third of low birth weight babies.
In developed countries , its overall incidence is about
3-10%
Term babies (5%)
Post term babies (15%)
CAUSES OF IUGR
The causes of IUGR can be grouped as
Maternal causes
Fetal causes
Placental causes
Uterine and Environmental causes.
MATERNAL CAUSES
Pregnancy weight of mother influences the fetal size
Chronic maternal disease condition
Renal disease condition
Malnutrition
Multiple pregnancy
Hypertensive disorders of pregnancy
Severe anemia
Previous baby suffered iugr etc.
FETAL CAUSES
Chromosomal anomalies
Exposure to an infection
German measles (rubella), cytomegalovirus, herpes simplex, tuberculosis, syphilis, or toxoplasmosis, TB, Malaria, Parvo virus
Birth defects
(cardiovascular, renal, anencephally, limb defect, etc).
• Placenta or umbilical cord defects.
PLACENTAL FACTORS
Uteroplacental Insufficiency
Fetoplacetal Insufficiency
Abruptio placenta
Placenta previa
Post term pregnancy
UTERINE CAUSES
Septate uterus
Fibroid/ myoma uterus
ENVIRONMENTAL CAUSES
High altitude - lower environmental oxygen saturation
Toxins
PATHOPHYSIOLOGY
Due to maternal and placental causes
Decrease in placental transfer of nutrients and oxygen to the fetus
Resulting in reduced fetal body store of lipids, glycogen
Causes neonatal hypoglycemia
Lack of oxygen
Chronic hypoxia that leads to erythropoietin production
Polycythemia etc
CLASSIFICATION OF IUGR
Based On Pathological Processes
I)Type I- Symmetrical
II)Type II- Asymmetrical
SYMMETRICAL
Symmetric IUGR: (33 % of IUGR Infants)
height, weight, head circumference proportional
early pregnancy insult:
commonly due to congenital infection, genetic disorder, or intrinsic factors
reduced no of cells in fetus
normal ponderal index
low risk of perinatal asphyxia
low risk of hypoglycemia
ASYMMETRICAL
later in pregnancy:
commonly due to utero placental insufficiency, maternal malnutrition, hypoxia, or extrinsic factors
low ponderal index
cell number remains same but size is small
increased risk of asphyxia
increased risk of hypoglycemia
CLINICAL FEATURES OF BABY WITH IUGR AT BIRTH
Weight deficit
Large head circumference
Old man look
Cartilaginous ridges on pinna
Dry wrinkled skin
Length remain unaffected
Open eyes
Well defined creases
Alert and active
Normal reflexes Normal cry
Thin umbilical
Scaphoid abdomen
Signs of recent wasting - soft tissue wasting - diminished skin fold thickness - decrease breast tissue - reduced thigh circumference • Signs of long term growth failure - Widened skull sutures, large fontanelles - shortened crown – heel length - delayed development of epiphyses
Normal reflexes Normal cry
Thin umbilical
Scaphoid abdomen
IUGR
Intrauterine growth restriction is said to be present in those babies whose birth weight is below the tength percentile of the average for gestational age.
INCIDENCE
Dysmaturity comprised about one third of low birth weight babies.
In developed countries , its overall incidence is about
3-10%
Term babies (5%)
Post term babies (15%)
CAUSES OF IUGR
The causes of IUGR can be grouped as
Maternal causes
Fetal causes
Placental causes
Uterine and Environmental causes.
MATERNAL CAUSES
Pregnancy weight of mother influences the fetal size
Chronic maternal disease condition
Renal disease condition
Malnutrition
Multiple pregnancy
Hypertensive disorders of pregnancy
Severe anemia
Previous baby suffered iugr etc.
FETAL CAUSES
Chromosomal anomalies
Exposure to an infection
German measles (rubella), cytomegalovirus, herpes simplex, tuberculosis, syphilis, or toxoplasmosis, TB, Malaria, Parvo virus
Birth defects
(cardiovascular, renal, anencephally, limb defect, etc).
• Placenta or umbilical cord defects.
PLACENTAL FACTORS
Uteroplacental Insufficiency
Fetoplacetal Insufficiency
Abruptio placenta
Placenta previa
Post term pregnancy
UTERINE CAUSES
Septate uterus
Fibroid/ myoma uterus
ENVIRONMENTAL CAUSES
High altitude - lower environmental oxygen saturation
Toxins
PATHOPHYSIOLOGY
Due to maternal and placental causes
Decrease in placental transfer of nutrients and oxygen to the fetus
Resulting in reduced fetal body store of lipids, glycogen
Causes neonatal hypoglycemia
Lack of oxygen
Chronic hypoxia that leads to erythropoietin production
Polycythemia etc
CLASSIFICATION OF IUGR
Based On Pathological Processes
I)Type I- Symmetrical
II)Type II- Asymmetrical
SYMMETRICAL
Symmetric IUGR: (33 % of IUGR Infants)
height, weight, head circumference proportional
early pregnancy insult:
commonly due to congenital infection, genetic disorder, or intrinsic factors
reduced no of cells in fetus
normal ponderal index
low risk of perinatal asphyxia
low risk of hypoglycemia
ASYMMETRICAL
later in pregnancy:
commonly due to utero placental insufficiency, maternal malnutrition, hypoxia, or extrinsic factors
low ponderal index
cell number remains same but size is small
increased risk of asphyxia
increased risk of hypoglycemia
CLINICAL FEATURES OF BABY WITH IUGR AT BIRTH
Weight deficit
Large head circumference
Old man look
Cartilaginous ridges on pinna
Dry wrinkled skin
Length remain unaffected
Open eyes
Well defined creases
Alert and active
Normal reflexes Normal cry
Thin umbilical
Scaphoid abdomen
Signs of recent wasting - soft tissue wasting - diminished skin fold thickness - decrease breast tissue - reduced thigh circumference • Signs of long term growth failure - Widened skull sutures, large fontanelles - shortened crown – heel length - delayed development of epiphyses
Normal reflexes Normal cry
Thin umbilical
Scaphoid abdomen
Rate Controlled Drug Delivery Systems, Activation Modulated Drug Delivery Systems, Mechanically activated, pH activated, Enzyme activated, Osmotic activated Drug Delivery Systems, Feedback regulated Drug Delivery Systems systems are discussed here.
Global launch of the Healthy Ageing and Prevention Index 2nd wave – alongside...ILC- UK
The Healthy Ageing and Prevention Index is an online tool created by ILC that ranks countries on six metrics including, life span, health span, work span, income, environmental performance, and happiness. The Index helps us understand how well countries have adapted to longevity and inform decision makers on what must be done to maximise the economic benefits that comes with living well for longer.
Alongside the 77th World Health Assembly in Geneva on 28 May 2024, we launched the second version of our Index, allowing us to track progress and give new insights into what needs to be done to keep populations healthier for longer.
The speakers included:
Professor Orazio Schillaci, Minister of Health, Italy
Dr Hans Groth, Chairman of the Board, World Demographic & Ageing Forum
Professor Ilona Kickbusch, Founder and Chair, Global Health Centre, Geneva Graduate Institute and co-chair, World Health Summit Council
Dr Natasha Azzopardi Muscat, Director, Country Health Policies and Systems Division, World Health Organisation EURO
Dr Marta Lomazzi, Executive Manager, World Federation of Public Health Associations
Dr Shyam Bishen, Head, Centre for Health and Healthcare and Member of the Executive Committee, World Economic Forum
Dr Karin Tegmark Wisell, Director General, Public Health Agency of Sweden
Rate Controlled Drug Delivery Systems, Activation Modulated Drug Delivery Systems, Mechanically activated, pH activated, Enzyme activated, Osmotic activated Drug Delivery Systems, Feedback regulated Drug Delivery Systems systems are discussed here.
Global launch of the Healthy Ageing and Prevention Index 2nd wave – alongside...ILC- UK
The Healthy Ageing and Prevention Index is an online tool created by ILC that ranks countries on six metrics including, life span, health span, work span, income, environmental performance, and happiness. The Index helps us understand how well countries have adapted to longevity and inform decision makers on what must be done to maximise the economic benefits that comes with living well for longer.
Alongside the 77th World Health Assembly in Geneva on 28 May 2024, we launched the second version of our Index, allowing us to track progress and give new insights into what needs to be done to keep populations healthier for longer.
The speakers included:
Professor Orazio Schillaci, Minister of Health, Italy
Dr Hans Groth, Chairman of the Board, World Demographic & Ageing Forum
Professor Ilona Kickbusch, Founder and Chair, Global Health Centre, Geneva Graduate Institute and co-chair, World Health Summit Council
Dr Natasha Azzopardi Muscat, Director, Country Health Policies and Systems Division, World Health Organisation EURO
Dr Marta Lomazzi, Executive Manager, World Federation of Public Health Associations
Dr Shyam Bishen, Head, Centre for Health and Healthcare and Member of the Executive Committee, World Economic Forum
Dr Karin Tegmark Wisell, Director General, Public Health Agency of Sweden
The Importance of Community Nursing Care.pdfAD Healthcare
NDIS and Community 24/7 Nursing Care is a specific type of support that may be provided under the NDIS for individuals with complex medical needs who require ongoing nursing care in a community setting, such as their home or a supported accommodation facility.
LGBTQ+ Adults: Unique Opportunities and Inclusive Approaches to CareVITASAuthor
This webinar helps clinicians understand the unique healthcare needs of the LGBTQ+ community, primarily in relation to end-of-life care. Topics include social and cultural background and challenges, healthcare disparities, advanced care planning, and strategies for reaching the community and improving quality of care.
Cold Sores: Causes, Treatments, and Prevention Strategies | The Lifesciences ...The Lifesciences Magazine
Cold Sores, medically known as herpes labialis, are caused by the herpes simplex virus (HSV). HSV-1 is primarily responsible for cold sores, although HSV-2 can also contribute in some cases.
PET CT beginners Guide covers some of the underrepresented topics in PET CTMiadAlsulami
This lecture briefly covers some of the underrepresented topics in Molecular imaging with cases , such as:
- Primary pleural tumors and pleural metastases.
- Distinguishing between MPM and Talc Pleurodesis.
- Urological tumors.
- The role of FDG PET in NET.
Under Pressure : Kenneth Kruk's StrategyKenneth Kruk
Kenneth Kruk's story of transforming challenges into opportunities by leading successful medical record transitions and bridging scientific knowledge gaps during COVID-19.
Deep Leg Vein Thrombosis (DVT): Meaning, Causes, Symptoms, Treatment, and Mor...The Lifesciences Magazine
Deep Leg Vein Thrombosis occurs when a blood clot forms in one or more of the deep veins in the legs. These clots can impede blood flow, leading to severe complications.
CHAPTER 1 SEMESTER V PREVENTIVE-PEDIATRICS.pdfSachin Sharma
This content provides an overview of preventive pediatrics. It defines preventive pediatrics as preventing disease and promoting children's physical, mental, and social well-being to achieve positive health. It discusses antenatal, postnatal, and social preventive pediatrics. It also covers various child health programs like immunization, breastfeeding, ICDS, and the roles of organizations like WHO, UNICEF, and nurses in preventive pediatrics.
Navigating Challenges: Mental Health, Legislation, and the Prison System in B...Guillermo Rivera
This conference will delve into the intricate intersections between mental health, legal frameworks, and the prison system in Bolivia. It aims to provide a comprehensive overview of the current challenges faced by mental health professionals working within the legislative and correctional landscapes. Topics of discussion will include the prevalence and impact of mental health issues among the incarcerated population, the effectiveness of existing mental health policies and legislation, and potential reforms to enhance the mental health support system within prisons.
TOP AND BEST GLUTE BUILDER A 606 | Fitking FitnessFitking Fitness
"Feature:
• Intelligent Ergonomically Design Glute Builder Is A Must Have For Those Looking To Target Their Gluteal Muscles And Hamstrings With Precision.
• The Ability To Adjust The Starting Position, This Machine Allows For A More Targeted Workout That Is Tailored To Your Specific Needs.
• Spacious And Supportive Cushioned Seat Provide Added Comfort And Stability During Your Workout."
Get more information visit on:- www.fitking.in
Our mail I.D:-care@fitking.in, fitking.in@gmail.com
Call us at :- 9958880790, 9870336406, 8800695917
TOP AND BEST GLUTE BUILDER A 606 | Fitking Fitness
vdocuments.mx_iugr-newedited.ppt
1. Definition :
• Intra uterine growth restriction is said to be
present in those babies whose birth weight is
below the tenth percentile of the average for
the gestational age.
• Growth restriction can occur in preterm, term
or post-term babies.
2. Nomenclature :
• SGA and IUGR are too often used synonymously
although there is a degree of overlap.
• SGA fetus is not necessarily growth retarded.
• The baby may be constitutionally small.
• Similarly late onset of pathological cessation of
growth may produce a baby with typical features of
IUGR but may not be small for gestation (ie.
Appropriate for gestational age).
• However, both attempt to identify fetuses or
neonates that are small for reasons other than being
preterm.
3. Normal fetal growth
• Is characterized by cellular
hyperplasia followed by
hyperplasia and hypertrophy and
lastly by hypertrophy alone.
4. Types: Based on the clinical evaluation and ultrasound
examination the small fetuses are divided into:
1. Fetuses that are small and healthy. The birth weight is
less than 10th percentile for their gestational age. They
have normal ponderal index, normal subcutaneous fat
and usually have uneventful neonatal course.
2. Fetuses where growth is restricted by pathological
process (true IUGR). Depending upon the relative
size of their head, abdomen and femur, the fetuses are
subdivided into:
(a) Symmetrical or Type I
(b) Asymmetrical or Type II.
5. Symmetrical (20%) –
• The fetus is affected from the noxious effect
very early in the phase of cellular hyperpllasia.
• The total cell number is less. This form of
growth retardation is most often caused by
structural or chromosomal abnormalities or
congenital infection (TORCH).
• The pathologic process is intrinsic to the fetus
and involves all the organs including the head.
6. Asymmetrical (80%) –
• The fetus is affected in later months during the
phase of cellular hypertrophy.
• The total cell number remains the same but size
is smaller than normal.
• The pathologic processes that too often result in
asymmetric growth retardation are maternal
diseases extrinsic to the fetus.
• These diseases alter the fetal size by reducing
utero-placental blood flow or by restricting the
oxygen and nutrient transfer or by reducing the
placental size.
7. Etiology: The causes of fetal growth retardation can be
divided into four types.
Maternal –
• Maternal nutrition before and during pregnancy –
Critical substrate requirement for the fetus such as
glucose, aminoacids and oxygen are lacking during
pregnancy.
• This is an important cause of small weight of the
babies in the developing countries.
• As most of the fetal weight gain (two-third) occurs
beyond 24th week of pregnancy, malnutrition,
anaemia, hypertension, antiphospholipid syndrome
in the second half of pregnancy play significant role
in the reduction of the birth weight.
8. Fetal –
There is enough substrate in the maternal blood and
also crosses the placenta but is not utilized by the
fetus. The failure of non utilization may be due to
(1) Congenital anomalies either cardio vascular, renal or
others
(2) Chromosomal abnormality is associated with 8-12%
of growth retarded infants. The common
abnormalities are trisomy 21, trisomy 18 (Edward’s
Syndrome), trisomy 16, trisomy 13 and Turner’s
syndrome
(3) Accelerated fetal metabolism due to TORCH agents
(toxoplasmosis, rubella, cytomegalovirus and herpes
simplex) and parvo virus B19
(4) Multiple pregnancy – There is mechanical hindrance
to growth and excessive fetal demand.
9. Placental –
• The causes include cases of poor uterine blood flow to
the placental site for a long time.
• This leads to chronic placental insufficiency with
inadequate substrate transfer.
• This occurs in conditions such as preeclampsia,
essential hypertension, chronic nephritis, organic heart
disease, placental and cord abnormalities such as
chronic placental abruption, infarction, small placenta,
circumvallate placenta, vellamentous insertion of cord
etc.
Unknown –
The cause remains unknown in about 40%
10. • Measurement of the abdominal girth showing
stationary or falling values.
• Serial clinical examination by abdominal
palpation to measure the relative growth of the
uterus and its contents is the commonly used
method. The diminishing amniotic fluid
volume can also be assessed with fair degree of
accuracy.
11. Physical features at birth
• Physical features show dry and wrinkled skin
because of less subcutaneous fat, scaphoid
abdomen, thin meconium stained vernix
caseosa and thin umbilical cord. All these give
the baby an ‘old man look’. Pinna of ear has
cartilaginous ridges. Plantar creases are well
defined.
• The baby is alert and having normal cry. Eyes
are open.
• Reflexes are normal including Moro-reflex.
12. Complications
Fetal:
(A) Antenatal – Chronic fetal distress, fetal death,
(B) Intranatal – Hypoxia and acidosis
(C) After birth:
Immediate:
(1) Asphyxia (intrauterine and neonatal),
(2) Hypoglycemia due to shortage of glycogen reserve in the
liver as a result of chronic hypoxia
(3) Meconium aspiration pneumonia
(4) Microcoagulation leading to DIC during first day of life.
(5) Hypothermia
(6) Pulmonary hemorrhage
(7) Polycythaemia
(8) Hyperviscosity syndrome
(9) Necrotizing enterocolitis due to reduced intestinal blood flow.
13. Late:
• Symmetrical growth retarded baby is likely to
grow slowly after birth.
• Whereas the asymmetrical one is more likely to
grow faster after birth.
• The fetuses have retardation of growth
evidenced before third trimester are likely to
have retarded neurologic and intellectual
development in infancy.
• The worst prognosis is for IUGR caused by
congenital infection, congenital abnormalities
and chromosomal defects.